FDA Inspection 857702 — OneLegacy

OneLegacy — FEI 3005880024

The FDA completed an inspection of OneLegacy on December 5, 2013 in Orange, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 5, 2013
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Orange, CA (United States)

Citations

IDCFRDescription
1234521 CFR 1271.190(b)(1)Clean, sanitary, orderly manner
1235321 CFR 1271.190(d)(1)Description of methods, schedule